018193614

ABECMA

---

February 5, 2020

Trademark Summary

The trademark application ABECMA was filed by Celgene Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on February 27, 2020, and it was registered by office on June 5, 2020 without any oppositions.

The application was filed in English (French was selected as the second language).

Deletion of the representative of the trademark registration was recorded on January 6, 2021. Appointment and Replacement of representative of the trademark registration was recorded on January 11, 2021. Change of name and professional address of the trademark registration was recorded on January 11, 2024. Change of name and address of the trademark registration was recorded on March 21, 2024.

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceutical preparations for use in the treatment of multiple myeloma, blood disease, cancer, diseases in the fields of oncology, immunology and inflammation
  2. Pharmaceutical preparations, namely, cytokine inhibitory drugs
  3. Pharmaceutical preparations that modulate the immune system.